The DOI matches its Crossref record; 288 of the 288 references it cites were found in a registry or an index.
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Open accessAbstract
TThe accumulation of misfolded proteins in the human brain is one of the critical features of many neurodegenerative diseases, including Alzheimer’s disease (AD). Assembles of beta-amyloid (Aβ) peptide – either soluble (oligomers - Aβ) or insoluble (plaques) and of tau protein, which form neurofibrillary tangles, are the major hallmarks of AD. Chaperones and co-chaperones regulate protein folding and client maturation, but they also target misfolded or aggregated proteins for refolding or for degradation, mostly by the proteasome. They form an important line of defense against misfolded proteins and are part of the cellular quality control system. The heat shock protein (Hsp) family, particularly Hsp70 and Hsp90, plays a major part in this process and it is well known to regulate protein misfolding in a variety of diseases, including tau levels and toxicity in AD. However, the role of Hsp90 in regulating protein misfolding is not yet fully understood. For example, knockdown of Hsp90 and its co-chaperones in a C. elegans model of Aβ misfolding leads to increased toxicity. On the other hand, the use of Hsp90 inhibitors in AD mouse models reduces Aβ toxicity, and normalizes synaptic function. Stress-inducible phosphoprotein 1 (STI1), an intracellular co-chaperone, mediates the transfer of clients from Hsp70 to Hsp90. Importantly, STI1 has been shown to regulate aggregation of amyloid-like proteins in yeast. In addition to its intracellular function, STI1 can be secreted by diverse cell types, including astrocytes and microglia and function as a neurotrophic ligand by triggering signaling via the cellular prion protein (PrPC). Extracellular STI1 can prevent Aβ toxic signaling by (i) interfering with Aβ binding to PrPC and (ii) triggering pro-survival signaling cascades. Interestingly, decreased levels of STI1 in C. elegans can also increase toxicity in an amyloid model. In this review, we will discuss the role of intracellular and extracellular STI1 and the Hsp70/Hsp90 chaperone network in mechanisms underlying protein misfolding in neurodegenerative diseases, with particular focus on Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 2×
“The first aggregated protein to be identified was Cu/Zn superoxide dismutase (SOD1; Rosen et al., 1993), then trans-active DNA binding protein-43 (TDP-43; Arai et al.”
BackgroundUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 3×
“…to increase early before plaque formation and correlate with the onset of the neurotoxic events, such as excitotoxicity, synaptic loss as well as impairment of LTP and learning/memory in rodent models (Lambert et al., 1998; Klein et al., 2001; Klein, 2002; Walsh et al., 2002; Wang et al., 2005).”
BackgroundNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 2×
“Augmented levels of α-synuclein or α-synuclein-containing aggregates are also characteristic of other neurodegenerative diseases including Lewy body dementia, multiple system atrophy and AD (Halliday et al., 2011; Serrano-Pozo et al., 2011; Ingelsson, 2016), forming a group of diseases termed “synucleinopathies.”
BackgroundMechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,564
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,553
The amyloid state and its association with protein misfolding diseases.
Knowles, T. P. J., Vendruscolo, M., & Dobson, C. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3810 · Cited by 2,382
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Mice devoid of PrP are resistant to scrapie
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., & Weissmann, C. (1993) · Cell · doi:10.1016/0092-8674(93)90360-3 · Cited by 2,100
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,098
A new puffing pattern induced by temperature shock and DNP in drosophila
Ritossa, F. (1962) · Experientia · doi:10.1007/bf02172188 · Cited by 2,068
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061 · cited 2×
“Aβ Peptide Generation and Toxicity Aβ peptides consisting of around 39–43 residues are formed by proteolytic cleavage of its precursor, APP, by beta-site APP cleaving enzyme (BACE, β-secretase) and by a γ-secretase complex, formed by several proteins including presenilins (O’Brien and Wong, 2011).”
BackgroundInclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979 · cited 1×
“Recent work suggests that the sequestering of toxic huntingin (Htt) into inclusion bodies may be a way to remove this toxic species as increased formation correlated with a reduction in levels of toxicity and neuronal death (Arrasate et al., 2004; Miller et al., 2010).”
BackgroundThe toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962 · cited 1×
“However, during the last two decades it has also become recognized that soluble Aβ oligomers (AβOs) are toxic to synapses (Lambert et al., 1998; Walsh et al., 2002; Ferreira and Klein, 2011; Benilova et al., 2012; Mucke and Selkoe, 2012; Lesne et al., 2013).”
BackgroundMorimoto, R. I. (1998) · Genes & Development · doi:10.1101/gad.12.24.3788 · Cited by 1,906
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
The distribution of tau in the mammalian central nervous system.
Binder, L. I., Frankfurter, A., & Rebhun, L. I. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.4.1371 · Cited by 1,588
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Molecular Chaperones and Protein Quality Control
Bukau, B., Weissman, J., & Horwich, A. (2006) · Cell · doi:10.1016/j.cell.2006.04.014 · Cited by 1,557
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
The Biology of Proteostasis in Aging and Disease
Labbadia, J., & Morimoto, R. I. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033955 · Cited by 1,472 · cited 2×
“Degradation of misfolded proteins by the ubiquitinproteasome system (UPS) or the autophagy-lysosome pathway (ALP; Labbadia and Morimoto, 2015; Yerbury et al., 2016) have been regarded as potential therapeutic targets for the treatment of neurodegenerative diseases, as aging leads to decreased efficiency of protein qua…”
BackgroundPathways and mechanisms of endocytic recycling
Grant, B. D., & Donaldson, J. G. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2755 · Cited by 1,424
Glover, J. R., & Lindquist, S. (1998) · Cell · doi:10.1016/s0092-8674(00)81223-4 · Cited by 1,357
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2779 · Cited by 1,335
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265 · cited 1×
“This result is paralleled by findings that activation or de-activation of synaptic activity, increases or decreases Aβ secretion, respectively (Kamenetz et al., 2003; Cirrito et al., 2005; Bero et al., 2011; Li et al., 2013; Yuan and Grutzendler, 2016).”
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
NMR structure of the mouse prion protein domain PrP(121–231)
Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., & Wüthrich, K. (1996) · Nature · doi:10.1038/382180a0 · Cited by 1,257
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227 · cited 3×
“Conversely, Auluck et al. (2002) also reported acceleration of α-synuclein toxicity after inducing a dominant negative mutation of fruit fly Hsp70, which further confirmed the critical role of Hsp70 in α-synuclein regulation.”
BackgroundProtein synthesis in salivary glands of Drosophila melanogaster: Relation to chromosome puffs
Tissiéres, A., Mitchell, H. K., & Tracy, U. M. (1974) · Journal of Molecular Biology · doi:10.1016/0022-2836(74)90447-1 · Cited by 1,227
The tetratricopeptide repeat: a structural motif mediating protein-protein interactions
Blatch, G. L., & Lässle, M. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199911)21:11<932::aid-bies5>3.0.co;2-n · Cited by 1,211
Structure of TPR Domain–Peptide Complexes
Scheufler, C., Brinker, A., Bourenkov, G., Pegoraro, S., Moroder, L., Bartunik, H., Hartl, F. U., & Moarefi, I. (2000) · Cell · doi:10.1016/s0092-8674(00)80830-2 · Cited by 1,188 · cited 1×
“STI1 possesses two Hsp70 binding sites located in TPR1 and TPR2B; however, it binds to Hsp70 in a 1:1 stoichiometry (Scheufler et al., 2000; Rohl et al., 2015b).”
BackgroundApoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,188
Converging concepts of protein folding in vitro and in vivo
Hartl, F. U., & Hayer-Hartl, M. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1591 · Cited by 1,185
Structure and mechanism of the Hsp90 molecular chaperone machinery
Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103
Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis
Brettschneider, J., Del Tredici, K., Toledo, J. B., Robinson, J. L., Irwin, D. J., Grossman, M., Suh, E., Van Deerlin, V. M., Wood, E. M., Baek, Y., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23937 · Cited by 1,065
The 90-kDa Molecular Chaperone Family
Csermely, P., Schnaider, T., So″ti, C., Prohászka, Z., & Nardai, G. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00013-8 · Cited by 1,028
Role of the Chaperone Protein Hsp104 in Propagation of the Yeast Prion-Like Factor [ psi + ]
Chernoff, Y. O., Lindquist, S. L., Ono, B.-I., Inge-Vechtomov, S. G., & Liebman, S. W. (1995) · Science · doi:10.1126/science.7754373 · Cited by 1,027
Modulation of neurodegeneration by molecular chaperones
Muchowski, P. J., & Wacker, J. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1587 · Cited by 1,024
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992 · cited 1×
“TDP-43 canmislocalize to the cytoplasm, be ubiquitinated, hyperphosphorylated and ultimately form aggregates (Neumann et al., 2006; Mackenzie et al., 2007; Sreedharan et al., 2008; Brettschneider et al., 2013).”
BackgroundTargeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967 · cited 1×
“…has shown that disrupted autophagy—either through autophagosomes or CMA—and lysosomal mechanisms contribute to the pathogenesis of AD, PD, HD, ALS, and FTD (Anglade et al., 1997; Nagata et al., 2004; Yu et al., 2005; Morimoto et al., 2007; Hu et al., 2010; Cuervo and Wong, 2014; Nah et al., 2015).”
BackgroundCrystal structure of an Hsp90–nucleotide–p23/Sba1 closed chaperone complex
Ali, M. M. U., Roe, S. M., Vaughan, C. K., Meyer, P., Panaretou, B., Piper, P. W., Prodromou, C., & Pearl, L. H. (2006) · Nature · doi:10.1038/nature04716 · Cited by 962 · cited 2×
“The Nterminal region contains an additional molecular lid mechanism, which crosses over the nucleotide-binding pocket in the ATPbound state and holds the nucleotide in place, but remains in the open conformation upon ADP-binding (Ali et al., 2006).”
BackgroundBallinger, C. A., Connell, P., Wu, Y., Hu, Z., Thompson, L. J., Yin, L.-Y., & Patterson, C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4535 · Cited by 943
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916 · cited 2×
“Interestingly, TDP43 misregulation has also been found in a proportion of patients with AD (Amador-Ortiz et al., 2007; Wilson et al., 2011).”
BackgroundNeuronal activity regulates the regional vulnerability to amyloid-β deposition
Bero, A. W., Yan, P., Roh, J. H., Cirrito, J. R., Stewart, F. R., Raichle, M. E., Lee, J.-M., & Holtzman, D. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2801 · Cited by 880
Protein disaggregation mediated by heat-shock protein Hspl04
Parsell, D. A., Kowal, A. S., Singer, M. A., & Lindquist, S. (1994) · Nature · doi:10.1038/372475a0 · Cited by 864
A review of Parkinson's disease
Davie, C. A. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn013 · Cited by 855
Parkinson's Disease and Parkinsonism: Neuropathology
Dickson, D. W. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009258 · Cited by 847
Chaperone-mediated autophagy: roles in disease and aging
Cuervo, A. M., & Wong, E. (2014) · Cell Research · doi:10.1038/cr.2013.153 · Cited by 846
Opposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation
Meacham, G. C., Patterson, C., Zhang, W., Younger, J. M., & Cyr, D. M. (2001) · Nature Cell Biology · doi:10.1038/35050509 · Cited by 839
Warrick, J. M., Chan, H. Y. E., Gray-Board, G. L., Chai, Y., Paulson, H. L., & Bonini, N. M. (1999) · Nature Genetics · doi:10.1038/70532 · Cited by 830
Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis
Dai, C., Whitesell, L., Rogers, A. B., & Lindquist, S. (2007) · Cell · doi:10.1016/j.cell.2007.07.020 · Cited by 826
Zhao, R., Davey, M., Hsu, Y.-C., Kaplanek, P., Tong, A., Parsons, A. B., Krogan, N., Cagney, G., Mai, D., Greenblatt, J., et al. (2005) · Cell · doi:10.1016/j.cell.2004.12.024 · Cited by 819
Rudiger, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1501 · Cited by 815
Han, T. W., Kato, M., Xie, S., Wu, L. C., Mirzaei, H., Pei, J., Chen, M., Xie, Y., Allen, J., Xiao, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.016 · Cited by 767
Ou, S. H., Wu, F., Harrich, D., García-Martínez, L. F., & Gaynor, R. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3584-3596.1995 · Cited by 758
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 723 · cited 4×
“A number of studies have shown that these hyperphosphorylated tau species can be recognized by Hsps and their co-chaperones, including Hsp27, Hsp70, CHIP, and αB crystalline, in order to repair malignant tau or proceed with its recycling (Dou et al., 2003; Dabir et al., 2004; Petrucelli et al., 2004; Shimura et al., 2…”
BackgroundInfluentialNMR characterization of the full‐length recombinant murine prion protein, m PrP(23–231)
Riek, R., Hornemann, S., Wider, G., Glockshuber, R., & Wüthrich, K. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00920-4 · Cited by 722
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
Link, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9368 · Cited by 687
Altered circadian activity rhythms and sleep in mice devoid of prion protein
Tobler, I., Gaus, S. E., Deboer, T., Achermann, P., Fischer, M., Rülicke, T., Moser, M., Oesch, B., McBride, P. A., & Manson, J. C. (1996) · Nature · doi:10.1038/380639a0 · Cited by 663
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., Wisniewski, T., Gunther, E. C., & Strittmatter, S. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3178 · Cited by 662
Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones
Frydman, J., Nimmesgern, E., Ohtsuka, K., & Hartl, F. U. (1994) · Nature · doi:10.1038/370111a0 · Cited by 653
Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging
Ben-Zvi, A., Miller, E. A., & Morimoto, R. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902882106 · Cited by 649 · cited 2×
“…autophagy-lysosome pathway (ALP; Labbadia and Morimoto, 2015; Yerbury et al., 2016) have been regarded as potential therapeutic targets for the treatment of neurodegenerative diseases, as aging leads to decreased efficiency of protein quality control (Ben-Zvi et al., 2009; Wang J. et al., 2009).”
BackgroundDickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29715 · Cited by 642 · cited 4×
“Inhibition of Hsp90 in HeLa cells transfected with mutant tau (P301L) increased CHIP complex formation with phosphorylated tau (p-tau) and CHIP selectively degraded these p-tau species, essentially preventing aggregation of p-tau (Dickey et al., 2007).”
BackgroundInfluentialBorkovich, K. A., Farrelly, F. W., Finkelstein, D. B., Taulien, J., & Lindquist, S. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3919 · Cited by 641
Structural determinants of the cellular localization and shuttling of TDP-43
Ayala, Y. M., Zago, P., D'Ambrogio, A., Xu, Y.-F., Petrucelli, L., Buratti, E., & Baralle, F. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.038950 · Cited by 630
Tetratrico peptide repeat interactions: to TPR or not to TPR?
Lamb, J. R., Tugendreich, S., & Hieter, P. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89037-4 · Cited by 626
Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A. M., & Mandelkow, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp367 · Cited by 617
Physiology of the prion protein
Linden, R., Martins, V. R., Prado, M. A. M., Cammarota, M., Izquierdo, I., & Brentani, R. R. (2008) · Physiological Reviews · doi:10.1152/physrev.00007.2007 · Cited by 617
Self-citationGlover, J. R., Kowal, A. S., Schirmer, E. C., Patino, M. M., Liu, J.-J., & Lindquist, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80264-0 · Cited by 597
A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease
Brehme, M., Voisine, C., Rolland, T., Wachi, S., Soper, J. H., Zhu, Y., Orton, K., Villella, A., Garza, D., Vidal, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.042 · Cited by 584
Protein aggregation in amyotrophic lateral sclerosis
Blokhuis, A. M., Groen, E. J. N., Koppers, M., van den Berg, L. H., & Pasterkamp, R. J. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1125-6 · Cited by 579
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Hsp104 is required for tolerance to many forms of stress.
Sanchez, Y., Taulien, J., Borkovich, K. A., & Lindquist, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05295.x · Cited by 564
Genetic Suppression of Polyglutamine Toxicity in Drosophila
Kazemi-Esfarjani, P., & Benzer, S. (2000) · Science · doi:10.1126/science.287.5459.1837 · Cited by 557
Exosome-dependent Trafficking of HSP70
Lancaster, G. I., & Febbraio, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502017200 · Cited by 546
Krobitsch, S., & Lindquist, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1589 · Cited by 542
Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin
Hu, F., Padukkavidana, T., Vægter, C. B., Brady, O. A., Zheng, Y., Mackenzie, I. R., Feldman, H. H., Nykjaer, A., & Strittmatter, S. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.034 · Cited by 536
WORKMAN, P., BURROWS, F., NECKERS, L., & ROSEN, N. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.012 · Cited by 521
Freibaum, B. D., Chitta, R. K., High, A. A., & Taylor, J. P. (2010) · Journal of Proteome Research · doi:10.1021/pr901076y · Cited by 514
Hsp70 Reduces α-Synuclein Aggregation and Toxicity
Klucken, J., Shin, Y., Masliah, E., Hyman, B. T., & McLean, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400255200 · Cited by 508
Meyer, P., Prodromou, C., Hu, B., Vaughan, C., Roe, S. M., Panaretou, B., Piper, P. W., & Pearl, L. H. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00065-0 · Cited by 491
Diverse Cellular Functions of the Hsp90 Molecular Chaperone Uncovered Using Systems Approaches
McClellan, A. J., Xia, Y., Deutschbauer, A. M., Davis, R. W., Gerstein, M., & Frydman, J. (2007) · Cell · doi:10.1016/j.cell.2007.07.036 · Cited by 474
CHIP: a link between the chaperone and proteasome systems
McDonough, H., & Patterson, C. (2003) · Cell Stress & Chaperones · doi:10.1379/1466-1268(2003)008<0303:calbtc>2.0.co;2 · Cited by 468
Chaperones increase association of tau protein with microtubules
Dou, F., Netzer, W. J., Tanemura, K., Li, F., Hartl, F. U., Takashima, A., Gouras, G. K., Greengard, P., & Xu, H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242720499 · Cited by 461
Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers
Jhaveri, K., Taldone, T., Modi, S., & Chiosis, G. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.10.008 · Cited by 456
Induction of heat shock proteins in B-cell exosomes
Clayton, A., Turkes, A., Navabi, H., Mason, M. D., & Tabi, Z. (2005) · Journal of Cell Science · doi:10.1242/jcs.02494 · Cited by 454
Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection
Zanata, S. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf325 · Cited by 445
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · cited 1×
“However, during the last two decades it has also become recognized that soluble Aβ oligomers (AβOs) are toxic to synapses (Lambert et al., 1998; Walsh et al., 2002; Ferreira and Klein, 2011; Benilova et al., 2012; Mucke and Selkoe, 2012; Lesne et al., 2013).”
BackgroundHip, a novel cochaperone involved in the eukaryotic hsc70/hsp40 reaction cycle
Höfeld, J., Minami, Y., & Hartl, F.-U. (1995) · Cell · doi:10.1016/0092-8674(95)90099-3 · Cited by 439
Jana, N. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.13.2009 · Cited by 432
Neuropathology underlying clinical variability in patients with synucleinopathies
Halliday, G. M., Holton, J. L., Revesz, T., & Dickson, D. W. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0852-9 · Cited by 430
Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones
Prodromou, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.754 · Cited by 425
Structure, Function and Regulation of the Hsp90 Machinery
Buchner, J., & Li, J. (2013) · Biomedical Journal · doi:10.4103/2319-4170.113230 · Cited by 420
Zhang, M., Windheim, M., Roe, S. M., Peggie, M., Cohen, P., Prodromou, C., & Pearl, L. H. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.023 · Cited by 420
The U box is a modified RING finger — a common domain in ubiquitination
Aravind, L., & Koonin, E. V. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00398-5 · Cited by 419
Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein
Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., & Strittmatter, S. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0395-10.2010 · Cited by 418
Brain amyloid-β oligomers in ageing and Alzheimer’s disease
Lesné, S. E., Sherman, M. A., Grant, M., Kuskowski, M., Schneider, J. A., Bennett, D. A., & Ashe, K. H. (2013) · Brain · doi:10.1093/brain/awt062 · Cited by 409
Human Hsp70 Disaggregase Reverses Parkinson’s-Linked α-Synuclein Amyloid Fibrils
Gao, X., Carroni, M., Nussbaum-Krammer, C., Mogk, A., Nillegoda, N. B., Szlachcic, A., Guilbride, D. L., Saibil, H. R., Mayer, M. P., & Bukau, B. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.012 · Cited by 407
A molecular chaperone complex at the lysosomal membrane is required for protein translocation
Agarraberes, F. A., & Dice, J. F. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2491 · Cited by 404
Axonal prion protein is required for peripheral myelin maintenance
Bremer, J., Baumann, F., Tiberi, C., Wessig, C., Fischer, H., Schwarz, P., Steele, A. D., Toyka, K. V., Nave, K.-A., Weis, J., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2483 · Cited by 402
Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Outeiro, T. F., Putcha, P., Tetzlaff, J. E., Spoelgen, R., Koker, M., Carvalho, F., Hyman, B. T., & McLean, P. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001867 · Cited by 401
Kirschke, E., Goswami, D., Southworth, D., Griffin, P. R., & Agard, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.04.038 · Cited by 399
Proteasomal Inhibition by α-Synuclein Filaments and Oligomers
Lindersson, E., Beedholm, R., Højrup, P., Moos, T., Gai, W., Hendil, K. B., & Jensen, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306390200 · Cited by 397
Marzec, M., Eletto, D., & Argon, Y. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.10.013 · Cited by 390
Cellular prion protein transduces neuroprotective signals
Chiarini, L. B. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf324 · Cited by 376
Multistep mechanism of substrate binding determines chaperone activity of Hsp70.
Bukau, B., Mayer, M. P., Schröder, H., Rüdiger, S., Paal, K., & Laufen, T. (2000) · Nature Structural Biology · doi:10.1038/76819 · Cited by 374
Hop Modulates hsp70/hsp90 Interactions in Protein Folding
Johnson, B. D., Schumacher, R. J., Ross, E. D., & Toft, D. O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3679 · Cited by 358
Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
Ingelsson, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00408 · Cited by 344
Polyglutamine neurodegeneration: protein misfolding revisited
Williams, A. J., & Paulson, H. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.004 · Cited by 341
Shorter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026319 · Cited by 338
The rat brain synucleins; family of proteins transiently associated with neuronal membrane
Maroteaux, L., & Scheller, R. H. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90043-w · Cited by 334
Hop as an Adaptor in the Heat Shock Protein 70 (Hsp70) and Hsp90 Chaperone Machinery
Chen, S., & Smith, D. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35194 · Cited by 334
GSK3: a possible link between beta amyloid peptide and tau protein
Hernández, F., Gómez de Barreda, E., Fuster-Matanzo, A., Lucas, J. J., & Avila, J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.011 · Cited by 327 · cited 2×
“Tau is abnormally phosphorylated in AD due to increased activity of GSK-3 and other tau kinases (Alvarez et al., 1999; Avila et al., 2010; Tremblay et al., 2010; Cavallini et al., 2013), likely as a result of initial Aβ toxicity (Tamagno et al., 2003; Ryan et al., 2009; Hernandez et al., 2010).”
BackgroundTorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregation
McLean, P. J., Kawamata, H., Shariff, S., Hewett, J., Sharma, N., Ueda, K., Breakefield, X. O., & Hyman, B. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01190.x · Cited by 324
Jana, N. R., Dikshit, P., Goswami, A., Kotliarova, S., Murata, S., Tanaka, K., & Nukina, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412042200 · Cited by 323
Accelerated neurodegeneration through chaperone-mediated oligomerization of tau
Blair, L. J., Nordhues, B. A., Hill, S. E., Scaglione, K. M., O’Leary, J. C., Fontaine, S. N., Breydo, L., Zhang, B., Li, P., Wang, L., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69003 · Cited by 322 · cited 3×
“Dickey and colleagues also found that FKBP51 expression is increased with age and in AD (Blair et al., 2013).”
BackgroundCHIP activates HSF1 and confers protection against apoptosis and cellular stress
Dai, Q. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg529 · Cited by 320
Hsp90-Tau complex reveals molecular basis for specificity in chaperone action
Karagöz, G. E., Duarte, A. M. S., Akoury, E., Ippel, H., Biernat, J., Morán Luengo, T., Radli, M., Didenko, T., Nordhues, B. A., Veprintsev, D. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.037 · Cited by 318 · cited 3×
“Structural studies involving binding to intrinsically disordered tau suggest that substrate recognition occurs through low-affinity hydrophobic interactions between the client protein and a large substratebinding interface onHsp90 (Zuehlke and Johnson, 2010; Karagoz et al., 2014).”
BackgroundCaloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease
Wang, J., Ho, L., Qin, W., Rocher, A. B., Seror, I., Humala, N., Maniar, K., Dolios, G., Wang, R., Hof, P. R., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3182fje · Cited by 316
Metazoan Hsp70 machines use Hsp110 to power protein disaggregation
Rampelt, H., Kirstein‐Miles, J., Nillegoda, N. B., Chi, K., Scholz, S. R., Morimoto, R. I., & Bukau, B. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.264 · Cited by 315
Prion-inducing domain 2–114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments
King, C.-Y., Tittmann, P., Gross, H., Gebert, R., Aebi, M., & Wüthrich, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6618 · Cited by 311
Swain, J. F., Dinler, G., Sivendran, R., Montgomery, D. L., Stotz, M., & Gierasch, L. M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.020 · Cited by 309
Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M.-Y. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297
The epichaperome is an integrated chaperome network that facilitates tumour survival
Rodina, A., Wang, T., Yan, P., Gomes, E. D., Dunphy, M. P. S., Pillarsetty, N., Koren, J., Gerecitano, J. F., Taldone, T., Zong, H., et al. (2016) · Nature · doi:10.1038/nature19807 · Cited by 289
Lopes, M. H., Hajj, G. N. M., Muras, A. G., Mancini, G. L., Castro, R. M. P. S., Ribeiro, K. C. B., Brentani, R. R., Linden, R., & Martins, V. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2313-05.2005 · Cited by 286
Wacker, J. L., Zareie, M. H., Fong, H., Sarikaya, M., & Muchowski, P. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb860 · Cited by 283
Structural Basis of Interdomain Communication in the Hsc70 Chaperone
Jiang, J., Prasad, K., Lafer, E. M., & Sousa, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.028 · Cited by 282
Luo, W., Dou, F., Rodina, A., Chip, S., Kim, J., Zhao, Q., Moulick, K., Aguirre, J., Wu, N., Greengard, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701055104 · Cited by 274
Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Avila, J., Bogónez, E., & Dı́az-Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270
Regulation of Hsp70 function by a eukaryotic DnaJ homolog.
Cyr, D. M., Lu, X., & Douglas, M. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36777-8 · Cited by 263
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90
Moulick, K., Ahn, J. H., Zong, H., Rodina, A., Cerchietti, L., Gomes DaGama, E. M., Caldas-Lopes, E., Beebe, K., Perna, F., Hatzi, K., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.670 · Cited by 261
Tsai, J., & Douglas, M. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9347 · Cited by 260
Hsp90 and co‐chaperones twist the functions of diverse client proteins
Zuehlke, A., & Johnson, J. L. (2010) · Biopolymers · doi:10.1002/bip.21292 · Cited by 251
J Proteins Catalytically Activate Hsp70 Molecules to Trap a Wide Range of Peptide Sequences
Misselwitz, B., Staeck, O., & Rapoport, T. A. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80158-6 · Cited by 250
Versatile TPR domains accommodate different modes of target protein recognition and function
Allan, R. K., & Ratajczak, T. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-010-0248-0 · Cited by 247
Isolation and characterization of STI1, a stress-inducible gene from Saccharomyces cerevisiae.
Nicolet, C. M., & Craig, E. A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3638 · Cited by 246
Heat Shock Prevents Alpha-synuclein-induced Apoptosis in a Yeast Model of Parkinson's Disease
Flower, T. R., Chesnokova, L. S., Froelich, C. A., Dixon, C., & Witt, S. N. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.060 · Cited by 238
Mitochondrial permeability transition pore in Alzheimer's disease: Cyclophilin D and amyloid beta
Du, H., & Yan, S. S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.005 · Cited by 238
Barry, A. E., Klyubin, I., Mc Donald, J. M., Mably, A. J., Farrell, M. A., Scott, M., Walsh, D. M., & Rowan, M. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6500-10.2011 · Cited by 237
Lotz, G. P., Lin, H., Harst, A., & Obermann, W. M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212761200 · Cited by 236
Autophagy in Neurodegenerative Diseases: From Mechanism to Therapeutic Approach
Nah, J., Yuan, J., & Jung, Y.-K. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0034 · Cited by 232
Walking the tightrope: proteostasis and neurodegenerative disease
Yerbury, J. J., Ooi, L., Dillin, A., Saunders, D. N., Hatters, D. M., Beart, P. M., Cashman, N. R., Wilson, M. R., & Ecroyd, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13575 · Cited by 232
The architecture of functional modules in the Hsp90 co‐chaperone Sti1/Hop
Schmid, A. B., Lagleder, S., Gräwert, M. A., Röhl, A., Hagn, F., Wandinger, S. K., Cox, M. B., Demmer, O., Richter, K., Groll, M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.472 · Cited by 229
Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability
Jinwal, U. K., Miyata, Y., Koren, J., Jones, J. R., Trotter, J. H., Chang, L., O'Leary, J., Morgan, D., Lee, D. C., Shults, C. L., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3345-09.2009 · Cited by 228
Specific Binding of Tetratricopeptide Repeat Proteins to the C-terminal 12-kDa Domain of hsp90
Young, J. C., Obermann, W. M. J., & Hartl, F. U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18007 · Cited by 227
Proteomic Identification of Novel Proteins in Cortical Lewy Bodies
Leverenz, J. B., Umar, I., Wang, Q., Montine, T. J., McMillan, P. J., Tsuang, D. W., Jin, J., Pan, C., Shin, J., Zhu, D., et al. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00048.x · Cited by 226
Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era
Paez-Colasante, X., Figueroa-Romero, C., Sakowski, S. A., Goutman, S. A., & Feldman, E. L. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.57 · Cited by 225
Increased autophagy in transgenic mice with a G93A mutant SOD1 gene
Morimoto, N., Nagai, M., Ohta, Y., Miyazaki, K., Kurata, T., Morimoto, M., Murakami, T., Takehisa, Y., Ikeda, Y., Kamiya, T., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.045 · Cited by 223
HSP90 inhibitors: current development and potential in cancer therapy
Sidera, K., & Patsavoudi, E. (2013) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/15748928113089990031 · Cited by 222 · cited 1×
“The most prominent drugs inhibit the ATPase activity of Hsp90 and are based on the geldanamycin, radicicol, or purine derivatives, which function as competitive inhibitors of ATP binding to Hsp90 (Roe et al., 1999; Sidera and Patsavoudi, 2014).”
BackgroundThe Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules
Jinwal, U. K., Koren, J., Borysov, S. I., Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson, A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-09.2010 · Cited by 214
Carmichael, J., Chatellier, J., Woolfson, A., Milstein, C., Fersht, A. R., & Rubinsztein, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170280697 · Cited by 211
Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration
Xilouri, M., Brekk, O. R., Landeck, N., Pitychoutis, P. M., Papasilekas, T., Papadopoulou-Daifoti, Z., Kirik, D., & Stefanis, L. (2013) · Brain · doi:10.1093/brain/awt131 · Cited by 205
Fontaine, S. N., Zheng, D., Sabbagh, J. J., Martin, M. D., Chaput, D., Darling, A., Trotter, J. H., Stothert, A. R., Nordhues, B. A., Lussier, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593489 · Cited by 205
Tamagno, E., Robino, G., Obbili, A., Bardini, P., Aragno, M., Parola, M., & Danni, O. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00059-6 · Cited by 201
Neuropathology of prion diseases
Budka, H. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.121 · Cited by 196
Marzo, V. (2014) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488980901140428100532 · Cited by 196
Mechanics of Hsp70 chaperones enables differential interaction with client proteins
Schlecht, R., Erbse, A. H., Bukau, B., & Mayer, M. P. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2006 · Cited by 194
Shimura, H., Miura-Shimura, Y., & Kosik, K. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400351200 · Cited by 193
TDP-43 in aging and Alzheimer's disease - a review.
Wilson, A. C., Dugger, B. N., Dickson, D. W., & Wang, D.-S. (2011) · PubMed · Cited by 192
Chaperone-dependent stabilization and degradation of p53 mutants
Muller, P., Hrstka, R., Coomber, D., Lane, D. P., & Vojtesek, B. (2008) · Oncogene · doi:10.1038/sj.onc.1211010 · Cited by 182
Chen, H.-J., Mitchell, J. C., Novoselov, S., Miller, J., Nishimura, A. L., Scotter, E. L., Vance, C. A., Cheetham, M. E., & Shaw, C. E. (2016) · Brain · doi:10.1093/brain/aww028 · Cited by 181
Putcha, P., Danzer, K. M., Kranich, L. R., Scott, A., Silinski, M., Mabbett, S., Hicks, C. D., Veal, J. M., Steed, P. M., Hyman, B. T., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.158436 · Cited by 179
Geldanamycin induces Hsp70 and prevents α-synuclein aggregation and toxicity in vitro
McLean, P. J., Klucken, J., Shin, Y., & Hyman, B. T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.021 · Cited by 177
Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones
Udan-Johns, M., Bengoechea, R., Bell, S., Shao, J., Diamond, M. I., True, H. L., Weihl, C. C., & Baloh, R. H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt408 · Cited by 177
Uryu, K., Richter‐Landsberg, C., Welch, W., Sun, E., Goldbaum, O., Norris, E. H., Pham, C.-T., Yazawa, I., Hilburger, K., Micsenyi, M. C., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050770 · Cited by 175
Co‐ and Post‐Translational Protein Folding in the ER
Ellgaard, L., McCaul, N., Chatsisvili, A., & Braakman, I. (2016) · Traffic · doi:10.1111/tra.12392 · Cited by 174
Goedert, M. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0466 · Cited by 172
Drosophila Piwi functions in Hsp90-mediated suppression of phenotypic variation
Gangaraju, V. K., Yin, H., Weiner, M. M., Wang, J., Huang, X., & Lin, H. (2010) · Nature Genetics · doi:10.1038/ng.743 · Cited by 167
Berson, A., Barbash, S., Shaltiel, G., Goll, Y., Hanin, G., Greenberg, D. S., Ketzef, M., Becker, A. J., Friedman, A., & Soreq, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100995 · Cited by 167
Dong, Z., Wolfer, D. P., Lipp, H., & Büeler, H. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.007 · Cited by 166
Tetratricopeptide repeat cochaperones in steroid receptor complexes
Smith, D. F. (2004) · Cell Stress and Chaperones · doi:10.1379/csc-31.1 · Cited by 165
Conserved Conformational Changes in the ATPase Cycle of Human Hsp90
Richter, K., Soroka, J., Skalniak, Ł., Leskovar, A., Heßling, M., Reinstein, J., & Büchner, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800540200 · Cited by 164
Zhang, Y., Gendron, T. F., Xu, Y.-F., Ko, L., Yen, S.-H. C., & Petrucelli, L. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-33 · Cited by 162
Lavery, L. A., Partridge, J. R., Ramelot, T. A., Elnatan, D., Kennedy, M. A., & Agard, D. A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.023 · Cited by 160
Dickey, C. A., Dunmore, J., Lu, B., Wang, J., Lee, W. C., Kamal, A., Burrows, F., Eckman, C., Hutton, M., & Petrucelli, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-5343fje · Cited by 160 · cited 1×
“Interestingly, inhibitors of Hsp90 decrease levels of phosphorylated tau, suggesting that Hsp90 may protect hyperphosphorylated tau from degradation (Dickey et al., 2006).”
BackgroundHonoré, B., Leffers, H., Madsen, P., Rasmussen, H. H., Vandekerckhove, J., & Celis, J. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42471-4 · Cited by 159
Miller, J., Arrasate, M., Shaby, B. A., Mitra, S., Masliah, E., & Finkbeiner, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0146-10.2010 · Cited by 159
Renkawek, K., Bosman, G. I. C. G. M., & JONG, W. W. D. (1994) · Acta Neuropathologica · doi:10.1007/bf00294178 · Cited by 154
Chung, E., Ji, Y., Sun, Y., Kascsak, R. J., Kascsak, R. B., Mehta, P. D., Strittmatter, S. M., & Wisniewski, T. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-130 · Cited by 152
Stress-inducible, Murine Protein mSTI1
Lässle, M., Blatch, G. L., Kundra, V., Takatori, T., & Zetter, B. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1876 · Cited by 151
Ávila, J., Wandosell, F. G., & Hernández, F. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.40 · Cited by 148
Cited by
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Boland, B., Yu, W. H., Corti, O., Mollereau, B., Henriques, A., Bezard, E., Pastores, G. M., Rubinsztein, D. C., Nixon, R. A., Duchen, M. R., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.109 · Cited by 558
Converging pathways in neurodegeneration, from genetics to mechanisms
Gan, L., Cookson, M. R., Petrucelli, L., & La Spada, A. R. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0237-7 · Cited by 479
Structure, Function, and Regulation of the Hsp90 Machinery
Biebl, M. M., & Buchner, J. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034017 · Cited by 304
Structure of Hsp90–Hsp70–Hop–GR reveals the Hsp90 client-loading mechanism
Wang, R. Y.-R., Noddings, C. M., Kirschke, E., Myasnikov, A. G., Johnson, J. L., & Agard, D. A. (2022) · Nature · doi:10.1038/s41586-021-04252-1 · Cited by 220
Metadata
- Authors
- Lackie, R. E., Maciejewski, A., Ostapchenko, V. G., Marques-Lopes, J., Choy, W.-Y., Duennwald, M. L., Prado, V. F., & Prado, M. A. M.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-05-16
- Volume
- 11
- Pages
- 254-254
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2614627885
- Cited by
- 374
- References
- 288
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.